Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence

Neuropsychopharmacology

Volumn 35, Issue 12, 2010, Pages 2392-2402

  Wessel, Jennifer ^a,d   McDonald, Sarah M ^a   Hinds, David A ^b   Stokowski, Renee P ^b   Javitz, Harold S ^a   Kennemer, Michael ^b   Krasnow, Ruth ^a   Dirks, William ^b   Hardin, Jill ^a   Pitts, Steven J ^b   Michel, Martha ^a   Jack, Lisa ^a   Ballinger, Dennis G ^b   McClure, Jennifer B ^c   Swan, Gary E ^a   Bergen, Andrew W ^a  

^a SRI INTERNATIONAL   (United States)

^b Perlegen Sciences Inc   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

candidate gene association scan; Fagerstr m test for nicotine dependence; single nucleotide polymorphism; treatmentseeking smokers

Indexed keywords

NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2;

ADULT; ALLELE; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; EUROPEAN AMERICAN; EXON; FAGERSTROM TEST; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; TOBACCO DEPENDENCE;

ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, NICOTINIC; TOBACCO USE DISORDER;

EID: 77958012303     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.120     Document Type: Article

References (89)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990). Basic local alignment search tool. J Mol Biol 215: 403-410.
2. Baker TB, Weiss RB, Bolt D, von Niederhausern A, Fiore MC, Dunn DM et al (2009). Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res 11: 785-796.
3. Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
4. Bergen AW, Caporaso N (1999). Cigarette smoking. J Natl Cancer Inst 91: 1365-1375.
5. Bergen AW, Conti DV, Van Den Berg D, Lee W, Liu J, Li D et al (2009). Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology 34: 2252-2264.
6. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X et al (2008). Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165: 1163-1171.
7. Bodmer W, Bonilla C (2008). Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40: 695-701.
8. Breitling LP, Dahmen N, Mittelstrass K, Illig T, Rujescu D, Raum E et al (2009a). Smoking cessation and variations in nicotinic acetylcholine receptor subunits alpha-5, alpha-3, and beta-4 genes. Biol Psychiatry 65: 691-695.
9. Breitling LP, Dahmen N, Mittelstrass K, Rujescu D, Gallinat J, Fehr C et al (2009b). Association of nicotinic acetylcholine receptor subunit alpha 4 polymorphisms with nicotine dependence in 5500 Germans. Pharmacogenomics J 9: 219-224.
10. Broms U, Madden PA, Heath AC, Pergadia ML, Shiffman S, Kaprio J (2007). The Nicotine Dependence Syndrome Scale in Finnish smokers. Drug Alcohol Depend 89: 42-51.
11. Buisson B, Bertrand D (2001). Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. J Neurosci 21: 1819-1829.
12. Changeux JP (2009). Nicotinic receptors and nicotine addiction. C R Biol 332: 421-425.
13. Chen GB, Payne TJ, Lou XY, Ma JZ, Zhu J, Li MD (2008). Association of amyloid precursor protein-binding protein, family B, member 1 with nicotine dependence in African and European American smokers. Hum Genet 124: 393-398.
14. Chen X, Chen J, Williamson VS, An SS, Hettema JM, Aggen SH et al (2009). Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 150B: 926-933.
15. Conneely KN, Boehnke M (2007). So many correlated tests, so little time! rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 81: 1158-1168.
16. Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD et al (2008). Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet 17: 2834-2848.
17. Craig DW, Pearson JV, Szelinger S, Sekar A, Redman M, Corneveaux JJ et al (2008). Identification of genetic variants using bar-coded multiplexed sequencing. Nat Methods 5: 887-893.
18. Dani JA, Bertrand D (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47: 699-729.
19. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB (2010). Rare variants create synthetic genome-wide associations. PLoS Biol 8: e1000294.
20. Drgon T, Johnson C, Walther D, Albino AP, Rose JE, Uhl GR (2009a). Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes. Mol Med 15: 268-274.
21. Drgon T, Montoya I, Johnson C, Liu QR, Walther D, Hamer D et al (2009b). Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Mol Med 15: 21-27.
22. Ehringer MA, Clegg HV, Collins AC, Corley RP, Crowley T, Hewitt JK et al (2007). Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. Am J Med Genet B Neuro-psychiatr Genet 144B: 596-604.
23. Etter JF, Hoda JC, Perroud N, Munafo M, Buresi C, Duret C et al (2009). Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence. Addict Behav 34: 772-775.
24. Fagerstrom K, Furberg H (2008). A comparison of the Fagerstrom test for nicotine dependence and smoking prevalence across countries. Addiction 103: 841-845.
25. Feng Y, Niu T, Xing H, Xu X, Chen C, Peng S et al (2004). A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet 75: 112-121.
26. Frazer KA, Murray SS, Schork NJ, Topol EJ (2009). Human genetic variation and its contribution to complex traits. Nat Rev Genet 10: 241-251.
27. Freathy RM, Ring SM, Shields B, Galobardes B, Knight B, Weedon MN et al (2009). A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Hum Mol Genet 18: 2922-2927.
28. Gauderman WJ (2002). Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 21: 35-50.
29. Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J et al (1998). Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 52: 173-185.
30. Greenbaum L, Kanyas K, Karni O, Merbl Y, Olender T, Horowitz A et al (2006). Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry 11: 312-322, 223.
31. Harismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY et al (2009). Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol 10: R32.
32. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991). The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86: 1119-1127.
33. Herraez DL, Stoneking M (2008). High fractions of exogenous DNA in human buccal samples reduce the quality of large-scale genotyping. Anal Biochem 383: 329-331.
34. Hinds DA, Stokowski RP, Patil N, Konvicka K, Kershenobich D, Cox DR et al (2004). Matching strategies for genetic association studies in structured populations. Am J Hum Genet 74: 317-325.
35. Hoft NR, Corley RP, McQueen MB, Schlaepfer IR, Huizinga D, Ehringer MA (2009). Genetic association of the CHRNA6 and CHRNB3 genes with tobacco dependence in a nationally representative sample. Neuropsychopharmacology 34: 698-706.
36. Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL et al (2007). CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry 64: 1078-1086.
37. Ioannidis JP (2008). Why most discovered true associations are inflated. Epidemiology 19: 640-648.
38. Keskitalo K, Broms U, Heliovaara M, Ripatti S, Surakka I, Perola M et al (2009). Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/ CHRNA5/CHRNB4) on chromosome 15. Hum Mol Genet 18: 4007-4012.
39. Kryukov GV, Shpunt A, Stamatoyannopoulos JA, Sunyaev SR (2009). Power of deep, all-exon resequencing for discovery of human trait genes. Proc Natl Acad Sci USA 106: 3871-3876.
40. Le Marchand L, Derby KS, Murphy SE, Hecht SS, Hatsukami D, Carmella SG et al (2008). Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res 68: 9137-9140.
41. Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F et al (2006). Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 31: 231-242.
42. Lessov CN, Martin NG, Statham DJ, Todorov AA, Slutske WS, Bucholz KK et al (2004). Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol Med 34: 865-879.
43. Li B, Leal SM (2008). Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 83: 311-321.
44. Li MD, Beuten J, Ma JZ, Payne TJ, Lou XY, Garcia V et al (2005). Ethnic-and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 14: 1211-1219.
45. Li MD, Cheng R, Ma JZ, Swan GE (2003). A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98: 23-31.
46. Li MD, Lou XY, Chen G, Ma JZ, Elston RC (2008). Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence. Biol Psychiatry 64: 951-957.
47. Li MD, Xu Q, Lou XY, Payne TJ, Niu T, Ma JZ (2009). Association and interaction analysis of variants in CHRNA5/CHRNA3/ CHRNB4 gene cluster with nicotine dependence in African and European Americans. Am J Med Genet B Neuropsychiatr Genet 153B: 745-756.
48. Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L et al (2010). Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 42: 436-440.
49. Liu YZ, Pei YF, Guo YF, Wang L, Liu XG, Yan H et al (2009). Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15. Mol Psychiatry 14: 668-680.
50. Lou XY, Chen GB, Yan L, Ma JZ, Mangold JE, Zhu J et al (2008). A combinatorial approach to detecting gene-gene and gene-environment interactions in family studies. Am J Hum Genet 83: 457-467.
51. Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC et al (2007). A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 80: 1125-1137.
52. Lou XY, Ma JZ, Payne TJ, Beuten J, Crew KM, Li MD (2006). Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetyl-choline receptor (CHRM1) with vulnerability for nicotine dependence. Hum Genet 120: 381-389.
53. Lueders KK, Hu S, McHugh L, Myakishev MV, Sirota LA, Hamer DH (2002). Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2). Nicotine Tob Res 4: 115-125.
54. Madsen BE, Browning SR (2009). A group-wise association test for rare mutations using a weighted sum statistic. PLoS Genet 5: e1000384.
55. Maes HH, Sullivan PF, Bulik CM, Neale MC, Prescott CA, Eaves LJ et al (2004). A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med 34: 1251-1261.
56. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA et al (2005). Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376-380.
57. Mineur YS, Picciotto MR (2008). Genetics of nicotinic acetyl-choline receptors: relevance to nicotine addiction. Biochem Pharmacol 75: 323-333.
58. Nievergelt CM, Libiger O, Schork NJ (2007). Generalized analysis of molecular variance. PLoS Genet 3: e51.
59. Nishita DM, Jack LM, McElroy M, McClure JB, Richards J, Swan GE et al (2009). Clinical trial participant characteristics and saliva and DNA metrics. BMC Med Res Methodol 9: 71.
60. Perkins KA, Lerman C, Coddington S, Jetton C, Karelitz JL, Wilson A et al (2008a). Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. Behav Pharmacol 19: 630-640.
61. Perkins KA, Lerman C, Grottenthaler A, Ciccocioppo MM, Milanak M, Conklin CA et al (2008b). Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behav Pharmacol 19: 641-649.
62. Perkins KA, Lerman C, Mercincavage M, Fonte CA, Briski JL (2009). Nicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch. Cancer Epidemiol Biomarkers Prev 18: 2608-2612.
63. Philibert RA, Todorov A, Andersen A, Hollenbeck N, Gunter T, Heath A et al (2009). Examination of the nicotine dependence (NICSNP) consortium findings in the Iowa adoption studies population. Nicotine Tob Res 11: 286-292.
64. Piper ME, McCarthy DE, Baker TB (2006). Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res 8: 339-351.
65. Rana BK, Wessel J, Mahboubi V, Rao F, Haeller J, Gayen JR et al (2009). Natural variation within the neuronal nicotinic acetyl-choline receptor cluster on human chromosome 15q24: influence on heritable autonomic traits in twin pairs. J Pharmacol Exp Ther 331: 419-428.
66. Rigbi A, Kanyas K, Yakir A, Greenbaum L, Pollak Y, Ben-Asher E et al (2008). Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function. Genes Brain Behav 7: 164-172.
67. Sabatelli M, Eusebi F, Al-Chalabi A, Conte A, Madia F, Luigetti M et al (2009). Rare missense variants of neuronal nicotinic acetylcholine receptor altering receptor function are associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet 18: 3997-4006.
68. Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML et al (2009a). Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet 150B: 453-466.
69. Saccone NL, Wang JC, Breslau N, Johnson EO, Hatsukami D, Saccone SF et al (2009b). The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 69: 6848-6856.
70. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA et al (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16: 36-49.
71. Sanger F, Nicklen S, Coulson AR (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467.
72. Schork NJ, Murray SS, Frazer KA, Topol EJ (2009). Common vs rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19: 212-219.
73. Schork NJ, Wessel J, Malo N (2008). DNA sequence-based phenotypic association analysis. Adv Genet 60: 195-217.
74. Sherva R, Wilhelmsen K, Pomerleau CS, Chasse SA, Rice JP, Snedecor SM et al (2008). Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with 'pleasurable buzz' during early experimentation with smoking. Addiction 103: 1544-1552.
75. Silverman MA, Neale MC, Sullivan PF, Harris-Kerr C, Wormley B, Sadek H et al (2000). Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence. Am J Med Genet 96: 646-653.
76. Spitz MR, Amos CI, Dong Q, Lin J, Wu X (2008). The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 100: 1552-1556.
77. Stevens VL, Bierut LJ, Talbot JT, Wang JC, Sun J, Hinrichs AL et al (2008). Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev 17: 3517-3525.
78. Stolerman IP, Jarvis MJ (1995). The scientific case that nicotine is addictive. Psychopharmacology (Berl) 117: 2-10;discussion 14-20.
79. Swan GE, McAfee T, Curry SJ, Jack LM, Javitz H, Dacey S et al (2003). Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med 163: 2337-2344.
80. Swan GE, McClure JB, Jack LM, Zbikowski SM, Javitz H, Catz SL et al (2010). Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med 38: 482-490.
81. TAG (2010). Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 42: 441-447.
82. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP et al (2008). A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642.
83. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F et al (2010). Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 42: 448-453.
84. Vink JM, Willemsen G, Boomsma DI (2005). Heritability of smoking initiation and nicotine dependence. Behav Genet 35: 397-406.
85. Wang J, Li MD (2010). Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. Neuropsychopharmacology 35: 702-719.
86. Wang JC, Grucza R, Cruchaga C, Hinrichs AL, Bertelsen S, Budde JP et al (2009). Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry 14: 501-510.
87. Wang K, Dickson SP, Stolle CA, Krantz ID, Goldstein DB, Hakonarson H (2010). Interpretation of association signals and identification of causal variants from genome-wide association studies. Am J Hum Genet 86: 730-742.
88. Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N et al (2008). A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 4: e1000125.
89. Wessel J, Schork NJ (2006). Generalized genomic distance-based regression methodology for multilocus association analysis. Am J Hum Genet 79: 792-806.